Key result
The CardioMEMS HF system provides remote hemodynamic monitoring for chronic heart failure patients, with summarized evidence supporting its efficacy and safety.
Why the study?
Remote hemodynamic monitoring may allow early intervention before clinical congestion to prevent heart failure hospitalizations, warranting a summary of the CardioMEMS HF system and its clinical evidence.
The CardioMEMS HF system provides a promising approach for remote hemodynamic monitoring to detect congestion early and prevent heart failure hospitalizations.
May support remote monitoring strategies in select HF patients; leaves open efficacy pending prospective randomized trials.
Remote monitoring is becoming increasingly important for management of chronic heart failure patients. Recently, hemodynamic monitoring by measuring intracardiac filling pressures has been gaining attention. It is believed that hemodynamic congestion precedes clinical congestion by several weeks and that remote hemodynamic monitoring therefore enables clinicians to intervene in an early stage and prevent heart failure hospitalizations. The CardioMEMS HF system (Abbott, CA, USA) is a sensor capable of measuring pulmonary artery pressures as a surrogate of left ventricular filling pressures. Clinical evidence for CardioMEMS has been convincing in terms of efficacy and safety. This article provides detailed information on the CardioMEMS HF system and summarizes all available evidence of this promising technique.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a review in chronic heart failure. CardioMEMS HF system was evaluated. The CardioMEMS HF system provides remote hemodynamic monitoring for chronic heart failure patients, with summarized evidence supporting its efficacy and safety.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: